Skip to main content

Table 3 Bivariate correlations of changes in hs-CRP, Hcy, and Apn with changes in other markers

From: Exploratory analysis of the effect of a controlled lifestyle intervention on inflammatory markers – the Healthy Lifestyle Community Programme (cohort 2)

Parameter changes

Correlations with hs-CRP change

(Δ[baseline, 1 year])

Correlations with Hcy change (Δ[baseline, 1 year])

Correlations with Apn change (Δ[baseline, 10 weeks])

r (CI)

p-value

n

r (CI)

P value

n

r (CI)

p-value

n

Body weight

0.231 (0.038; 0.408)

0.018

104

-0.132

(-0.305; 0.049)

0.152

120

0.254

(0.090; 0.405)

0.002

141

BMI

0.241 (0.048; 0.417)

0.014

104

-0.130

(-0.303; 0.051)

0.156

120

0.267

(0.103; 0.416)

0.001

141

WC

0.415 (0.234; 0.568)

 < 0.001

104

-0.163

(-0.334; 0.019)

0.077

119

0.256

(0.092; 0.406)

0.002

141

Systolic BP

0.031

(-0.163; 0.222)

0.755

104

0.065

(-0.116; 0.242)

0.479

120

0.064

(-0.103; 0.228)

0.449

140

Diastolic BP

-0.075

(-0.264; 0.120)

0.448

104

0.006

(-0.173; 0.185)

0.945

120

0.183

(0.016; 0.340)

0.031

140

Pulse pressure

0.070

(-0.125; 0.259)

0.483

104

0.073

(-0.108; 0.249)

0.426

120

0.002

(-0.164; 0.168)

0.982

140

RHR

0.077

(-0.118; 0.266)

0.438

104

-0.100

(-0.275; 0.081)

0.276

120

0.019

(-0.147; 0.184)

0.821

140

TC

0.010

(-0.183; 0.202)

0.923

104

-0.009

(-0.188; 0.171)

0.923

120

0.251

(0.087; 0.402)

0.003

141

LDL-C (meas.)

-0.035

(-0.226; 0.159)

0.726

104

0.003

(-0.176; 0.182)

0.977

120

0.159

(-0.008; 0.317)

0.059

141

LDL-C (calc.)

0.029

(-0.165; 0.221)

0.767

103

-0.033

(-0.212; 0.148)

0.720

119

0.200

(0.034; 0.356)

0.018

140

non-HDL-C

0.045

(-0.149; 0.236)

0.653

104

-0.048

(-0.225; 0.132)

0.601

120

0.251

(0.087; 0.402)

0.003

141

REM-C

0.191

(-0.003; 0.372)

0.052

104

-0.186

(-0.355;

-0.005)

0.041

120

0.203

(0.037; 0.358)

0.016

141

HDL-C

-0.138

(-0.323; 0.057)

0.161

104

0.075

(-0.106; 0.251)

0.416

120

0.133

(-0.034; 0.293)

0.115

141

TAG

0.137

(-0.058; 0.322)

0.167

104

-0.133

(-0.306; 0.048)

0.148

120

0.092

(-0.075; 0.254)

0.280

141

Glucose

0.216 (0.022; 0.394)

0.028

104

-0.083

(-0.259; 0.098)

0.370

120

-0.071

(-0.234; 0.096)

0.405

141

HbA1c

0.131

(-0.064; 0.316)

0.185

104

0.136

(-0.045; 0.308)

0.137

120

0.104

(-0.063; 0.265)

0.219

141

Insulin

0.066

(-0.128; 0.256)

0.503

104

-0.051

(-0.228; 0.130)

0.582

120

0.174

(0.008; 0.331)

0.039

141

hs-CRP

-

-

-

-

-

-

0.122

(-0.060; 0.296)

0.187

119

Hcy

-0.264

(-0.448; -0.059)

0.011

92

-

-

-

-0.052

(-0.216; 0.114)

0.542

141

PDI

-0.045

(-0.239; 0.153)

0.660

100

0.110

(-0.076; 0.289)

0.244

114

-0.178

(-0.342;

-0.004)

0.044

129

hPDI

0.042

(-0.156; 0.237)

0.676

100

-0.064

(-0.245; 0.122)

0.497

114

-0.195

(-0.357;

-0.021)

0.027

129

uPDI

-0.006

(-0.202; 0.191)

0.956

100

-0.116

(-0.294; 0.070)

0.218

114

0.134

(-0.041; 0.301)

0.130

129

  1. Participants of both the intervention and control groups are combined. hs-CRP High-sensitivity C-reactive protein, Hcy Homocysteine, Apn Adiponectin, r: Spearman correlation coefficients, CI 95% Confidence interval, BMI Body mass index, WC Waist circumference, BP Blood pressure, RHR Resting heart rate, TC Total cholesterol, LDL-C (meas.) Measured LDL cholesterol, LDL-C (calc.) Calculated LDL-C, non-HDL-C Non-HDL cholesterol, REM-C Remnant cholesterol, HDL-C HDL cholesterol, TAG Triglycerides, PDI Plant-based diet index, hPDI Healthful PDI, uPDI Unhealthful PDI